Vitamin D deficiency in Kazakhstan: Cross-Sectional study.


Journal

The Journal of steroid biochemistry and molecular biology
ISSN: 1879-1220
Titre abrégé: J Steroid Biochem Mol Biol
Pays: England
ID NLM: 9015483

Informations de publication

Date de publication:
05 2020
Historique:
received: 14 09 2019
revised: 03 12 2019
accepted: 04 12 2019
pubmed: 10 12 2019
medline: 13 8 2020
entrez: 9 12 2019
Statut: ppublish

Résumé

Vitamin D deficiency (VDD) is one of the serious and highly debatable public health problems affecting at least one billion of world population. This study objected to evaluate Vitamin D status in adult population of both sexes residing in different geographical areas of Kazakhstan and to elucidate the possible contributing factors related to VDD. This cross-sectional study covered 6 regions of Kazakhstan and applied the systematic random sampling to recruit 1347 healthy adults (of whom 819 were females) with mean age 44 ± 14 years. The concentration of 25-hydroxy vitamin D (25-OHD) was measured from May 2018 to August 2018 with Architect 25OH Vitamin D assay (Abbott Ireland Diagnostics Division Lisnamuck, Longford Co. Longford Ireland). Vitamin D deficiency was defined as 25-OHD values not exceeding 20 ng/mL as a reference threshold in healthy population. The median serum 25(OH)D concentrations in all studied regions of Kazakhstan were below the reference threshold (20 ng/mL). The lowest range of vitamin D (<10 ng/mL) was observed more commonly in females (34.6 % - 283) as compared to males (16.7 % - 88) and was significantly higher in Asians (33.2 % - 352) in contrast with Caucasians (6.7 % - 19) (χ2 = 177,939; D.f. = 3; p-value=<0,001). The proportion of severe VDD was higher in individuals with low body mass index (31.1 % - 188) vs. individuals with high body mass index (18.7 % - 50). In this study individuals aged 60 years and older had the most favorable situation with 25-OHD concentrations since these were normal in 14.4 % of observations (χ2 = 26,589; D.f. = 6; p-value=<0001). Studying the prevalence of VDD is an important public health task. Further research is needed to understand the epidemiology of VDD in more details to tailor intervention programs.

Identifiants

pubmed: 31812522
pii: S0960-0760(19)30567-9
doi: 10.1016/j.jsbmb.2019.105565
pii:
doi:

Substances chimiques

Vitamin D 1406-16-2
25-hydroxyvitamin D A288AR3C9H

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

105565

Informations de copyright

Copyright © 2019 Elsevier Ltd. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest No conflict of interest for any of the authors.

Auteurs

Olga Gromova (O)

Federal Research Center «Computer Science and Control» of the Russian Academy of Sciences, Moscow, Russia; Institute of Bioelementology, Moscow, Russia.

Aikerm Doschanova (A)

Medical Center "Talmas Medicus", Astana, Kazakhstan; Association of Obstetricians and Gynecologists of Astana, Astana, Kazakhstan.

Vyacheslav Lokshin (V)

Persona International Clinical Center for Reproductology, Almaty, Kazakhstan; Association of Reproductive Medicine, Almaty, Kazakhstan.

Ainur Tuletova (A)

Medical Center "Talmas Medicus", Astana, Kazakhstan.

Galina Grebennikova (G)

Institute of Reproductive Medicine, Almaty, Kazakhstan.

Laura Daniyarova (L)

Asfendiyarov Kazakh National Medical University, Almaty, Kazakhstan.

Gulnaz Kaishibayeva (G)

Institute of Neurology Named after Smagul Kayshibaev, Almaty, Kazakhstan.

Tair Nurpeissov (T)

Republican Center of Allergology, Almaty, Kazakhstan.

Viktoriya Khan (V)

Republican Center of Allergology, Almaty, Kazakhstan.

Yuliya Semenova (Y)

Department of Neurology, Ophthalmology and Otolaryngology, Semey Medical University, Semey, Kazakhstan.

Albina Chibisova (A)

Pharmaceutical Company "Unipharm INC", Almaty, Kazakhstan.

Natalia Suzdalskaya (N)

Pharmaceutical Company "Unipharm INC", Almaty, Kazakhstan.

Zhanara Aitaly (Z)

Federal Research Center «Computer Science and Control» of the Russian Academy of Sciences, Moscow, Russia.

Natalia Glushkova (N)

Department of Personalized Medicine, Semey Medical University, Semey, Kazakhstan. Electronic address: glushkovanatalyae@gmail.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH